LFG
WST icon

Larson Financial Group’s West Pharmaceutical WST Stock Holding History

Larson Financial Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$421K Sell
1,174
-1,583
-57% -$484K 0.01% 605
2026
Q1 		$691K Buy
2,757
+225
+9% +$56K 0.02% 393
2025
Q4 		$697K Sell
2,532
-270
-10% -$73.9K 0.02% 384
2025
Q3 		$735K Buy
2,802
+195
+7% +$47.4K 0.03% 372
2025
Q2 		$570K Buy
2,607
+384
+17% +$82.1K 0.02% 399
2025
Q1 		$498K Buy
2,223
+2,160
+3,429% +$595K 0.02% 410
2024
Q4 		$20.6K Buy
63
+59
+1,475% +$18.6K ﹤0.01% 1207
2024
Q3 		$1.2K Buy
4
+1
+33% +$306 ﹤0.01% 1952
2024
Q2 		$988 Sell
3
-27
-90% -$9.54K ﹤0.01% 1710
2024
Q1 		$11.9K Hold
30
– – ﹤0.01% 1002
2023
Q4 		$10.6K Sell
30
-8
-21% -$2.83K ﹤0.01% 1001
2023
Q3 		$14.3K Buy
38
+11
+41% +$4.25K ﹤0.01% 905
2023
Q2 		$10.4K Hold
27
– – ﹤0.01% 921
2023
Q1 		$9.38K Hold
27
– – ﹤0.01% 939
2022
Q4 		$6.37K Hold
27
– – ﹤0.01% 983
2022
Q3 		$7K Buy
+27
New +$8.22K ﹤0.01% 897

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Larson Financial Group's WST Position: Q2 2026 in Review

Larson Financial Group reduced its West Pharmaceutical (WST) stake by 57% in Q2 2026, selling an estimated $484K and leaving 1,174 shares worth $421K. The position accounts for 0.01% of the portfolio, ranked #605.

Larson Financial Group first reported a position in WST in Q3 2022 and has held it in 16 quarters since. The position peaked at $735K in Q3 2025. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Larson Financial Group held 1,174 shares of West Pharmaceutical worth $421K as of Q2 2026.
  • Larson Financial Group sold 1,583 West Pharmaceutical shares in Q2 2026, an estimated $484K.
  • West Pharmaceutical made up 0.01% of Larson Financial Group's portfolio in Q2 2026, its #605 holding.
  • Larson Financial Group first reported a position in West Pharmaceutical in Q3 2022 and has held it in 16 quarters since.
  • Larson Financial Group's West Pharmaceutical position peaked at $735K in Q3 2025.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.